Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study.
paper
Cited
Public
Unavailable
- Authors
- Crump, Casey; Winkleby, Marilyn A; Sundquist, Kristina; Sundquist, Jan
- Year
- 2013
- Journal
- The American journal of psychiatry
- PMID
- 23318474
- DOI
- 10.1176/appi.ajp.2012.12050599
OBJECTIVE: Schizophrenia is associated with premature mortality, but the specific causes and pathways are unclear. The authors used outpatient and inpatient data for a national population to examine the association between schizophrenia and mortality and comorbidities. METHOD: This was a national cohort study of 6,097,834 Swedish adults, including 8,277 with schizophrenia, followed for 7 years (2003-2009) for mortality and comorbidities diagnosed in any outpatient or inpatient setting nationwide. RESULTS: On average, men with schizophrenia died 15 years earlier, and women 12 years earlier, than the rest of the population, and this was not accounted for by unnatural deaths. The leading causes were ischemic heart disease and cancer. Despite having twice as many health care system contacts, schizophrenia patients had no increased risk of nonfatal ischemic heart disease or cancer diagnoses, but they had an elevated mortality from ischemic heart disease (adjusted hazard ratio for women, 3.33 [95% CI=2.73-4.05]; for men, 2.20 [95% CI=1.83-2.65]) and cancer (adjusted hazard ratio for women, 1.71 [95% CI=1.38-2.10; for men, 1.44 [95% CI=1.15-1.80]). Among all people who died from ischemic heart disease or cancer, schizophrenia patients were less likely than others to have been diagnosed previously with these conditions (for ischemic heart disease, 26.3% compared with 43.7%; for cancer, 73.9% compared with 82.3%). The association between schizophrenia and mortality was stronger among women and the employed. Lack of antipsychotic treatment was also associated with elevated mortality. CONCLUSIONS: Schizophrenia patients had markedly premature mortality, and the leading causes were ischemic heart disease and cancer, which appeared to be underdiagnosed. Preventive interventions should prioritize primary health care tailored to this population, including more effective risk modification and screening for cardiovascular disease and cancer.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Real-world comprehensive care of people living with schizophrenia: recommendations across different settings and clinical stages. | Fusar-Poli P et al. | β | 2026 | β |
| The Impact of Preexisting Severe Mental Disorders on Cancer Mortality: A Systematic Review and Meta-Analysis. | Riis N et al. | β | 2026 | β |
| The past and future of integrated biopsychosocial whole-health perspectives in psychiatric rehabilitation. | Wolfe R et al. | β | 2026 | β |
| A retrospective and comprehensive analysis of excess life-years lost, mortality risk, and cause of death among severe mental illness in China. | Fang X et al. | β | 2025 | β |
| Assessment of Urban-Rural Differences in Schizophrenia Mortality in the United States Using the CDC-WONDER Database: A Retrospective Study. | Bote SK et al. | β | 2025 | β |
| Association between the number of acute episodes and increased cardiac left ventricular mass index in patients diagnosed with schizophrenia. | Chen PH et al. | β | 2025 | β |
| A systematic review of randomized controlled trials in a general practice setting aiming to reduce excess all-cause mortality and enhance cardiovascular health in patients with severe mental illness. | Langkilde K et al. | β | 2025 | β |
| Colorectal cancer mortality in persons with severe mental illness: a scoping review with meta-analyses of observational studies. | Pop PR et al. | β | 2025 | β |
| Comorbidities and HIV-related factors associated with mental health symptoms and unhealthy substance use among older adults living with HIV in low- and middle-income countries: a cross-sectional study. | Ross JL et al. | β | 2025 | β |
| Comparative mortality risk of antipsychotics in 41,695 patients with schizophrenia: an 11-year population-based cohort study in Hong Kong. | Fang CZ et al. | β | 2025 | β |
| COPD and Schizophrenia. | Ratcliffe S et al. | β | 2025 | β |
| Diagnostic inequalities relating to physical healthcare among people with mental health conditions: a systematic review. | Liberati E et al. | β | 2025 | β |
| Diagnostic pathways and mortality across psychotic disorders: Evidence from Catalonia integrated health records. | Madero S et al. | β | 2025 | β |
| External stress, formaldehyde, and schizophrenia: a new mouse model for mental illness research. | Cheng J et al. | β | 2025 | β |
| Health Perceptions and Risk of Metabolic Syndrome and Diabetes in Psychiatric Patients. | ΓztΓΌrk Ε et al. | β | 2025 | β |
| Inclusion in the cancer patient pathway among cancer patients with and without pre-existing mental or substance use disorders: a nationwide register-based study. | Heiberg IH et al. | β | 2025 | β |
| Increased mortality risk in people with schizophrenia in Lithuania 2001-2020. | Drevinskaite M et al. | β | 2025 | β |
| Increased risk of early lung function alterations in people with psychosis: A cross-sectional case-control study. | Viejo Casas A et al. | β | 2025 | β |
| Managing health in dual diagnosis: narratives from individuals with schizophrenia and diabetes. | Zerne Nilsson M et al. | β | 2025 | β |
| Palliative Electroconvulsive Therapy: A Descriptive Cohort Study. | Robbins-Welty GA et al. | β | 2025 | β |
| Patients' experience of patient-reported outcomes, continuous feedback, and a solution-focused approach (using DIALOGβ+) in psychosis care in Sweden. | Lundmark M et al. | β | 2025 | β |
| Relationship Between Family Support, C-Reactive Protein and Body Mass Index Among Outpatients with Schizophrenia. | Pachi A et al. | β | 2025 | β |
| Schizophrenia and physical illness: a coordinated care failure. | Larsson LG et al. | β | 2025 | β |
| Sex-stratified mortality estimates in people with schizophrenia: A systematic review and meta-analysis of cohort studies of 2,700,825 people with schizophrenia. | Solmi M et al. | β | 2025 | β |
| Shared medication coordination in a social psychiatric residence: adaptation to meet local requirements. | Axelsen TB et al. | β | 2025 | β |
| Socioeconomic position, psychiatric medical treatment and risk of breast cancer recurrence and mortality: A Danish population-based cohort study. | Asmussen FB et al. | β | 2025 | β |
| The prevalence and clinical correlates of severe anxiety symptoms in first-episode drug-naΓ―ve schizophrenia: a Chinese population study. | Xu P et al. | β | 2025 | β |
| Treatment and long-term outcome of mental disorders: The grim picture from a quasi-epidemiological investigation in 54,826 subjects from 40 countries. | Fountoulakis KN et al. | β | 2025 | β |
| What is behind the 17-year life expectancy gap between individuals with schizophrenia and the general population? | Popa AV et al. | β | 2025 | β |
| Accelerated Pace of Aging in Schizophrenia: Five Case-Control Studies. | Caspi A et al. | β | 2024 | β |
| A comprehensive update on genetic inheritance, epigenetic factors, associated pathology, and recent therapeutic intervention by gene therapy in schizophrenia. | R R et al. | β | 2024 | β |
| A functional schizophrenia-associated genetic variant near the TSNARE1 and ADGRB1 genes. | Wahbeh MH et al. | β | 2024 | β |
| Aging of persons with schizophrenia: analysis of a national dataset. | Taube C et al. | β | 2024 | β |
| Association between preferred language and use of mental health services among home care recipients with schizophrenia spectrum and other psychotic disorders: A retrospective cohort study in Ontario, Canada, 2010 to 2015. | Carson S et al. | β | 2024 | β |
| Association of antipsychotic formulations with sudden cardiac death in patients with schizophrenia: A nationwide population-based case-control study. | Hsieh KP et al. | β | 2024 | β |
| Cancer incidence following non-neoplastic medical conditions: a prospective population-based cohort study. | SipilΓ€ LJ et al. | β | 2024 | β |
| Conceptualization and characterization of "primary" and "secondary" cognitive impairment in schizophrenia. | Vita A et al. | β | 2024 | β |
| Correlation of health literacy, health management self-efficacy, and attitude in elderly patients with schizophrenia: A cross-sectional study. | Liao SJ et al. | β | 2024 | β |
| COVID-19-associated mortality in individuals with serious mental disorders in Sweden during the first two years of the pandemic- a population-based register study. | Gibbs A et al. | β | 2024 | β |
| Definition, assessment and treatment of cognitive impairment associated with schizophrenia: expert opinion and practical recommendations. | Vita A et al. | β | 2024 | β |
| Developing a prediction model to identify people with severe mental illness without regular contact to their GP - a study based on data from the Danish national registers. | Naesager AHD et al. | β | 2024 | β |
| Effects of antipsychotic treatment on cardio-cerebrovascular related mortality in schizophrenia: A subanalysis of a systematic review and meta-analysis with meta-regression of moderators. | Solmi M et al. | β | 2024 | β |
| General medical comorbidities in psychotic disorders in the Finnish SUPER study. | Ahti J et al. | β | 2024 | β |
| Impact of non-participation bias due to psychiatric illness on mortality and cardiovascular event estimates: a Danish longitudinal population study. | Rygner Z et al. | β | 2024 | β |
| Individuals with psychosis present a reduced lung diffusion capacity and early spirometry alterations: Results from a cross-sectional study. | Viejo Casas A et al. | β | 2024 | β |
| Integrating Electronic Health Records and Polygenic Risk to Identify Genetically Unrelated Comorbidities of Schizophrenia That May Be Modifiable. | Vessels T et al. | β | 2024 | β |
| Investigating the Relationship between Schizophrenia and Incidence Risk of Breast Cancer: A Systematic Review and Meta-Analysis of Cohort Studies. | Mahdavinoor SMM et al. | β | 2024 | β |
| Is the long-term poor prognosis of acute myocardial infarction in patients with mental illness mediated through their poor adherence with recommended healthcare? | Corrao G et al. | β | 2024 | β |
| Low lung function in Bipolar Disorder and Schizophrenia: a hidden risk. | Ruiz-Rull C et al. | β | 2024 | β |
| [Metabolic syndrome and antipsychotic therapy of schizophrenia]. | Petrova NN et al. | β | 2024 | β |
| Mortality rate in patients in a long-term psychiatric care facility in Johannesburg. | Mathekga M et al. | β | 2024 | β |
| Navigating complexity: healthcare providers' experiences with integrating physical health promotion in psychosis outpatient services in Sweden. | Zerne Nilsson M et al. | β | 2024 | β |
| Palliative Care Psychiatry: Building Synergy Across the Spectrum. | Shalev D et al. | β | 2024 | β |
| Physical health challenges faced by elders with severe mental illness: population-based retrospective cohort study. | Chang CK et al. | β | 2024 | β |
| Predictors of adherence to exercise interventions in people with schizophrenia. | Schwaiger R et al. | β | 2024 | β |
| Prescriptions of psychotropic and somatic medications among patients with severe mental disorders and healthy controls in a naturalistic study. | Shafi DES et al. | β | 2024 | β |
| Rates of colorectal cancer diagnosis and mortality in people with severe mental illness: results from Australia's National Bowel Cancer Screening Programme. | Kisely S et al. | β | 2024 | β |
| Regional differences in mortality risk and in attenuating or aggravating factors in schizophrenia: A systematic review and meta-analysis. | Solmi M et al. | β | 2024 | β |
| Relationship between eating attitudes, depression, and insight in schizophrenic patients with and without type 2 diabetes mellitus: a comparative study in Guangdong, China. | Zhou W et al. | β | 2024 | β |
| Schizophrenia and type 2 diabetes risk: a systematic review and meta-analysis. | Dong K et al. | β | 2024 | β |
| Severe mental illness and infectious disease mortality: aΒ systematic review and meta-analysis. | Ronaldson A et al. | β | 2024 | β |
| Sex differences in the association between suicidal ideation and neurocognitive function in Chinese patients with schizophrenia. | Wu F et al. | β | 2024 | β |
| Sleep apnea in schizophrenia: Estimating prevalence and impact on cognition. | Ghazikhanian SE et al. | β | 2024 | β |
| Temporal trends in mortality and associated factors among persons with mental disorders: A register-based cohort study. | Yang M et al. | β | 2024 | β |
| The association between schizophrenia and increased Covid-19 mortality in a cohort of over 2 million people in Brazil. | Oliveira FES et al. | β | 2024 | β |
| The association of lower urinary tract symptoms with schizophrenia and its treatments: A narrative review. | Schofield E et al. | β | 2024 | β |
| The Finnish Adoptive Family Study of Schizophrenia: differences in somatic diseases and conditions between adoptees with high or low genetic risk for schizophrenia spectrum disorders. | Karjalainen E et al. | β | 2024 | β |
| Using a systems thinking approach to explore the complex relationships between schizophrenia and premature mortality. | Ali S et al. | β | 2024 | β |
| Using qualitative exit interviews to explore schizophrenia burden and treatment experience in clinical trial patients. | Simmons A et al. | β | 2024 | β |
| Antipsychotics and Mortality in Adult and Geriatric Patients with Schizophrenia. | Yeh LL et al. | β | 2023 | β |
| Association between neighborhood deprivation and mortality in patients with schizophrenia and bipolar disorder-A nationwide follow-up study. | JansΓ₯ker F et al. | β | 2023 | β |
| Association between risk of dementia and very late-onset schizophrenia-like psychosis: a Swedish population-based cohort study. | Stafford J et al. | β | 2023 | β |
| Association of family history of schizophrenia and clinical outcomes in individuals with eating disorders. | Zhang R et al. | β | 2023 | β |
| A Systematic Review on the Potential of Aspirin to Reduce Cardiovascular Risk in Schizophrenia. | Dao J et al. | β | 2023 | β |
| Breast Cancer Screening Among Females With and Without Schizophrenia. | O'Neill B et al. | β | 2023 | β |
| Clinical Laboratory Data in Japan: A Comparative Study of Patients with Psychiatric Disorders and the General Population. | Iwata M et al. | β | 2023 | β |
| Genetic liability to mental disorders in relation to the risk of hypertension. | Huangfu N et al. | β | 2023 | β |
| Health outcomes in primary care: a 20-year evidence map of randomized controlled trials. | Missiou A et al. | β | 2023 | β |
| Impact of mental disorders on clinical outcomes of physical diseases: an umbrella review assessing population attributable fraction and generalized impact fraction. | Dragioti E et al. | β | 2023 | β |
| Improving kidney care for people with severe mental health difficulties: a thematic analysis of twenty-two healthcare providers' perspectives. | Cogley C et al. | β | 2023 | β |
| "InMotion"-Mixed physical exercise program with creative movement as an intervention for adults with schizophrenia: study protocol for a randomized controlled trial. | Poikonen H et al. | β | 2023 | β |
| Introducing extended consultations for patients with severe mental illness in general practice: Results from the SOFIA feasibility study. | JΓΈnsson ABR et al. | β | 2023 | β |
| Life expectancy and years of potential life lost in people with mental disorders: a systematic review and meta-analysis. | Chan JKN et al. | β | 2023 | β |
| Life is pain: Fibromyalgia as a nexus of multiple liability distributions. | Moscati A et al. | β | 2023 | β |
| Longitudinal study of the course and outcome of first-episode psychosis. | Prakash J et al. | β | 2023 | β |
| Metabolic profile in first episode drug naΓ―ve patients with psychosis and its relation to cognitive functions and social cognition: a case control study. | Sayed SE et al. | β | 2023 | β |
| Monitoring the Effectiveness of Treatment in Women with Schizophrenia: New Specialized Cooperative Approaches. | Natividad M et al. | β | 2023 | β |
| More must be done to reduce cardiovascular risk for patients on antipsychotic medications. | Osimo EF et al. | β | 2023 | β |
| Mortality and excess life-years lost in patients with schizophrenia under community care: a 5-year follow-up cohort study. | Ren J et al. | β | 2023 | β |
| Mortality rates in people with first diagnosis of schizophrenia-spectrum disorders: A 5-year population-based cohort study. | Yung NCL et al. | β | 2023 | β |
| Physical and psychiatric comorbidities among patients with severe mental illness as seen in Uganda. | Mpango RS et al. | β | 2023 | β |
| Physical health disparities and severe mental illness: A longitudinal comparative cohort study using hospital data in Northern Ireland. | McCarter R et al. | β | 2023 | β |
| Postsurgical morbidity and mortality favorably informs deep brain stimulation for new indications including schizophrenia and schizoaffective disorder. | Gault JM et al. | β | 2023 | β |
| Predictors of Mortality Following a Schizophrenia Spectrum Diagnosis: Evidence From the 20-Year Follow-up of the OPUS Randomized Controlled Trial. | Starzer MSK et al. | β | 2023 | β |
| Psychometric and clinical evaluation of schizophrenia remission criteria in outpatients with psychotic disorders. | Sakinyte K et al. | β | 2023 | β |
| Schizophrenia and co-morbidity risk: Evidence from a data driven phenomewide association study. | Mulugeta A et al. | β | 2023 | β |
| Schizophrenia as a risk factor for cardiovascular and metabolic health outcomes: a comparative risk assessment. | Ali S et al. | β | 2023 | β |
| The effects of sociodemographic factors and comorbidities on sepsis: A nationwide Swedish cohort study. | Stenberg H et al. | β | 2023 | β |
| The Protective Effect of Clozapine on Suicide: A Population Mortality Study of Statewide Autopsy Records in Maryland. | Lee BJ et al. | β | 2023 | β |
| The relationship between psychopathology, occupational balance, and quality of life among people with schizophrenia. | Ercan DoΔu S et al. | β | 2023 | β |
| The risk of hospitalization for psychotic disorders following hospitalization for COVID-19: a French nationwide longitudinal study | Pignon B et al. | β | 2023 | β |
| The Role of Bias in Clinical Decision-Making of People with Serious Mental Illness and Medical Co-morbidities: a Scoping Review. | Crapanzano KA et al. | β | 2023 | β |
| Unfavorable cancer mortality-to-incidence ratios in patients with schizophrenia: A nationwide cohort study in Taiwan, 2000-2019. | Cheng CS et al. | β | 2023 | β |
| Unmet needs with antipsychotic treatment in schizophrenia and bipolar I disorder: patient perspectives from qualitative focus groups. | Doane MJ et al. | β | 2023 | β |
| Variability of glucose, insulin, and lipid disturbances in first-episode psychosis: a meta-analysis. | Pillinger T et al. | β | 2023 | β |
| What are patients' experiences of discontinuing clozapine and how does this impact their views on subsequent treatment? | Southern J et al. | β | 2023 | β |
| Allostatic load and systemic comorbidities in psychiatric disorders. | Finlay S et al. | β | 2022 | β |
| An integrative study of the microbiome gut-brain-axis and hippocampal inflammation in psychosis: Persistent effects from mode of birth. | Joe P et al. | β | 2022 | β |
| Association of multimorbidity of non-communicable diseases with mortality: a 10-year prospective study of 0.5 million Chinese adults. | Zou S et al. | β | 2022 | β |
| Chorioamnionitis and risk of long-term neurodevelopmental disorders in the offspring: a response. | Tsamantioti E et al. | β | 2022 | β |
| Disparities in oral anticoagulation initiation in patients with schizophrenia and atrial fibrillation: A nationwide cohort study. | HΓΈjen AA et al. | β | 2022 | β |
| Domains of Vulnerability, Resilience, Health Habits, and Mental and Physical Health for Health Disparities Research. | Wolfe RM et al. | β | 2022 | β |
| Echocardiographic study of cardiac structure and function in people with bipolar disorder after midlife. | Chen PH et al. | β | 2022 | β |
| Effects of exercise on mortality rates of individuals with severe mental illness. | Baron DA et al. | β | 2022 | β |
| Excess mortality in severe mental disorders: A systematic review and meta-regression. | Ali S et al. | β | 2022 | β |
| Experiences and Perspectives of GC-MS Application for the Search of Low Molecular Weight Discriminants of Schizophrenia. | Porozova N et al. | β | 2022 | β |
| Factors and their weight in reducing life expectancy in schizophrenia. | Correll CU et al. | β | 2022 | β |
| Gastrointestinal and liver disease in patients with schizophrenia: A narrative review. | Grant RK et al. | β | 2022 | β |
| Impact of a Mental Health Diagnosis on Emergency Department Adherence to Sepsis Care Guidelines. | Crapanzano KA et al. | β | 2022 | β |
| Improving Healthy Living in Residential Care Facilities: Feasibility, Acceptability, and Appropriateness of Implementing a Multicomponent Intervention for Diabetes Risk Reduction in Adults with Serious Mental Illnesses. | Sommerfeld DH et al. | β | 2022 | β |
| Long-term effects of antipsychotics on mortality in patients with schizophrenia: a systematic review and meta-analysis. | Jia N et al. | β | 2022 | β |
| Minding metabolism: targeted interventions to improve cardio-metabolic monitoring across early and chronic psychosis. | Kelly JR et al. | β | 2022 | β |
| Mortality in people with schizophrenia: a systematic review and meta-analysis of relative risk and aggravating or attenuating factors. | Correll CU et al. | β | 2022 | β |
| Mortality in Schizophrenia-Spectrum Disorders: Recent Advances in Understanding and Management. | Peritogiannis V et al. | β | 2022 | β |
| Mortality, Revascularization, and Cardioprotective Pharmacotherapy After Acute Coronary Syndrome in Patients With Severe Mental Illness: A Systematic Review and Meta-analysis. | Chan JKN et al. | β | 2022 | β |
| Movement Disorders and Mortality in Severely Mentally Ill Patients: The Curacao Extrapyramidal Syndromes Study XIV. | Willems AE et al. | β | 2022 | β |
| Nature and Extent of Physical Comorbidities Among Korean Patients With Mental Illnesses: Pairwise and Network Analysis Based on Health Insurance Claims Data. | Kim HJ et al. | β | 2022 | β |
| Novel disease associations with schizophrenia genetic risk revealed in ~400,000 UK Biobank participants. | Zhang R et al. | β | 2022 | β |
| Obesity: An Independent Risk Factor for Complications in Anterior Lumbar Interbody Fusion? A Systematic Review. | Feeley A et al. | β | 2022 | β |
| Patient-centric characterization of multimorbidity trajectories in patients with severe mental illnesses: A temporal bipartite network modeling approach. | Wang T et al. | β | 2022 | β |
| Patients' acceptability and implementation outcomes of a case management approach to encourage participation in colorectal cancer screening for people with schizophrenia: a qualitative secondary analysis of a mixed-method randomised clinical trial. | Yamada Y et al. | β | 2022 | β |
| Physical Health Impairment and Exercise as Medicine in Severe Mental Disorders: A Narrative Review. | Brobakken MF et al. | β | 2022 | β |
| Predictors of competitive employment in individuals with severe mental illness: results from an observational, cross-sectional study in Germany. | GΓΌhne U et al. | β | 2022 | β |
| Prevalence of lifetime nonmedical opioid use among U.S. Health Center Patients aged 45 years and older with psychiatric disorders. | Brooks JM et al. | β | 2022 | β |
| Psychiatric disorders and risk of subsequent dementia: Systematic review and meta-analysis of longitudinal studies. | Stafford J et al. | β | 2022 | β |
| Psychiatry is essential for now but might eventually disappear (although this is unlikely to happen any time soon). | Kelly BD | β | 2022 | β |
| Sleep quality and its relationship to mental health, physical health and health behaviours among young adults with serious mental illness enrolled in a lifestyle intervention trial. | Aschbrenner KA et al. | β | 2022 | β |
| Study protocol for a randomized trial of bridge: Person-centered collaborative care for serious mental illness and cancer. | Irwin KE et al. | β | 2022 | β |
| Temporal trends in associations between severe mental illness and risk of cardiovascular disease: A systematic review and meta-analysis. | Lambert AM et al. | β | 2022 | β |
| The Association of Mental Health Disorders with Takotsubo Syndrome (Broken Heart Syndrome) Among Older Women. | Appiah D et al. | β | 2022 | β |
| The Cumulative Effect of Antipsychotic Usage on Mortality in Schizophrenia: A Nationwide Population-based Cohort Study in Korea. | Kim G et al. | β | 2022 | β |
| The evaluation of a physical health promotion intervention for people with severe mental illness receiving community based accommodational support: a mixed-method pilot study. | Kirschner V et al. | β | 2022 | β |
| The Impact of the COVID-19 Pandemic on the Lifestyles and Levels of Anxiety and Depression of Patients with Schizophrenia: A Retrospective Observational Study. | BiviΓ‘-Roig G et al. | β | 2022 | β |
| The pharmacological treatment of schizophrenia: How far have we come? | Rubio JM et al. | β | 2022 | β |
| Accelerated aging signatures in subjects with schizophrenia and their unaffected siblings. | RebouΓ§as DB et al. | β | 2021 | β |
| Age Effect on Incidence, Physical, and Psychiatric Comorbidity for Sudden Cardiac Death in Schizophrenia: Effet de l'Γ’ge sur l'incidence, la comorbiditΓ© physique et psychiatrique de la mort cardiaque subite dans la schizophrΓ©nie. | Chen PH et al. | β | 2021 | β |
| Association between preexisting mental illnesses and mortality among medicaid-insured women diagnosed with breast cancer. | Lawrence WR et al. | β | 2021 | β |
| Associations of the <i>SREBF2</i> Gene and <i>INSIG2</i> Polymorphisms with Obesity and Dyslipidemia in Thai Psychotic Disorder Patients Treated with Risperidone. | Vanwong N et al. | β | 2021 | β |
| Brain capillary structures of schizophrenia cases and controls show a correlation with their neuron structures. | Saiga R et al. | β | 2021 | β |
| Cancer care for people with mental disorders: A qualitative survey among cancer care and psychiatric care professionals in Japan. | Etoh T et al. | β | 2021 | β |
| Childhood Trauma and Insomnia Increase Suicidal Ideation in Schizophrenia Patients: A Cross-Sectional Study. | Zhang Y et al. | β | 2021 | β |
| Colorectal cancer Outcomes in people with Severe Mental Illness Cohort (COSMIC): a protocol for an Australian retrospective cohort using linked administrative data. | Protani MM et al. | β | 2021 | β |
| Comorbidity and Treatment in Older Psychiatric In-patients-A Retrospective Study in a Chinese Psychiatric Hospital. | Liu H et al. | β | 2021 | β |
| COVID-19 Prevalence and Mortality Among Schizophrenia Patients: A Large-Scale Retrospective Cohort Study. | Tzur Bitan D et al. | β | 2021 | β |
| Current and emerging long-acting antipsychotics for the treatment of schizophrenia. | de Filippis R et al. | β | 2021 | β |
| Disparities in Screening and Treatment of Cardiovascular Diseases in Patients With Mental Disorders Across the World: Systematic Review and Meta-Analysis of 47 Observational Studies. | Solmi M et al. | β | 2021 | β |
| Encouraging participation in colorectal cancer screening for people with schizophrenia: A randomized controlled trial. | Fujiwara M et al. | β | 2021 | β |
| Excess Mortality and Life-Years Lost in People With Schizophrenia and Other Non-affective Psychoses: An 11-Year Population-Based Cohort Study. | Yung NCL et al. | β | 2021 | β |
| Excess mortality in patients with schizophrenia spectrum disorders in Malaga (Spain): A cohort study. | Moreno-KΓΌstner B et al. | β | 2021 | β |
| Feasibility and Acceptability of a Collaborative Lung Cancer Screening Educational Intervention Tailored for Individuals With Serious Mental Illness. | Flores EJ et al. | β | 2021 | β |
| Feeding and Eating Disorder and Risk of Subsequent Neurodevelopmental Disorders: A Population-Based Cohort Study. | Shan H et al. | β | 2021 | β |
| First-episode psychosis: How long does it last? A review of evolution and trajectory. | Prakash J et al. | β | 2021 | β |
| Forensic psychiatry and Covid-19: accelerating transformation in forensic psychiatry. | Kennedy HG et al. | β | 2021 | β |
| High Risk and Trajectories of Physical Illnesses before the Diagnosis of Bipolar Disorder. | Chen PH et al. | β | 2021 | β |
| Identifying multimodal signatures underlying the somatic comorbidity of psychosis: the COMMITMENT roadmap. | Schwarz E et al. | β | 2021 | β |
| Increased Risks of Death and Hospitalization in Influenza/Pneumonia and Sepsis for Individuals Affected by Psychotic Disorders, Bipolar Disorders, and Single Manic Episodes: A Retrospective Cross-Sectional Study. | Nilsson NH et al. | β | 2021 | β |
| Inequalities in Psychiatric Service Use and Mortality by Migrant Status Following a First Diagnosis of Psychotic Disorder: A Swedish Cohort Study of 1.3M People. | Katsampa D et al. | β | 2021 | β |
| Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries. | Mishu MP et al. | β | 2021 | β |
| Long Acting Injectable Antipsychotics in the Treatment of Schizophrenia and Bipolar Disorder. | DevrΔ±mcΔ± ΓzgΓΌven H et al. | β | 2021 | β |
| Low-dose clozapine-related seizure: A case report and literature review. | Le DS et al. | β | 2021 | β |
| Management of Cardiovascular Health in People with Severe Mental Disorders. | Lemogne C et al. | β | 2021 | β |
| Mechanisms Underlying the Comorbidity of Schizophrenia and Type 2 Diabetes Mellitus. | Mizuki Y et al. | β | 2021 | β |
| Morbidity and mortality in schizophrenia with comorbid substance use disorders. | LΓ€hteenvuo M et al. | β | 2021 | β |
| Mortality and non-use of antipsychotic drugs after acute admission in schizophrenia: A prospective total-cohort study. | StrΓΈmme MF et al. | β | 2021 | β |
| Mortality from cancer in people with severe mental disorders in Emilia Romagna Region, Italy. | Grassi L et al. | β | 2021 | β |
| Mortality gap and physical comorbidity of people with severe mental disorders: the public health scandal. | Fiorillo A et al. | β | 2021 | β |
| Profile of recipients of holistic health counselling in a psychiatric OPD in South India. | Gandhi S et al. | β | 2021 | β |
| Risks of all-cause death and completed suicide in patients with schizophrenia/schizoaffective disorder treated with long-acting injectable or oral antipsychotics: A population-based retrospective cohort study in Taiwan. | Tang CH et al. | β | 2021 | β |
| Severe mental illness is associated with increased mortality and severe course of COVID-19. | Barcella CA et al. | β | 2021 | β |
| Systemic lupus erythematosus and autoimmune features in chronic hospitalized patients with schizophrenia. | Chen YM et al. | β | 2021 | β |
| The risk of physical multimorbidity in people with psychotic disorders: A systematic review and meta-analysis. | Rodrigues M et al. | β | 2021 | β |
| The SOFIA pilot trial: a cluster-randomized trial of coordinated, co-produced care to reduce mortality and improve quality of life in people with severe mental illness in the general practice setting. | Rozing MP et al. | β | 2021 | β |
| Unveiling the Metabolic Profile of First-Episode Drug-NaΓ―ve Schizophrenia Patients: Baseline Characteristics of a Longitudinal Study Among Han Chinese. | Zhang Q et al. | β | 2021 | β |
| 20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20). | Taipale H et al. | β | 2020 | β |
| A cross-sectional study on metabolic similarities and differences between inpatients with schizophrenia and those with mood disorders. | Uju Y et al. | β | 2020 | β |
| An appraisal of methodology reporting in lifestyle interventions among people with psychosis: A systematic review. | Mucheru D et al. | β | 2020 | β |
| Cardiac left ventricular ejection fraction in men and women with schizophrenia on long-term antipsychotic treatment. | Andreou D et al. | β | 2020 | β |
| Chronic smoking and cognition in patients with schizophrenia: A meta-analysis. | Coustals N et al. | β | 2020 | β |
| Commentary on Robert Whitaker's viewpoint. | Tiihonen J et al. | β | 2020 | β |
| Cost-effectiveness of aripiprazole orally disintegrating tablets in the treatment of schizophrenia in China. | Lin Z et al. | β | 2020 | β |
| Cross-sectional mixed-methods study protocol exploring the enablers and barriers for people with severe and enduring mental illness in Jamaica when accessing healthcare for chronic physical illness. | Whitehorne-Smith P et al. | β | 2020 | β |
| D2 dopamine receptor gene (DRD2) Taq1A (rs1800497) affects bone density. | Chiang TI et al. | β | 2020 | β |
| Death Associated With Coronavirus (COVID-19) Infection in Individuals With Severe Mental Disorders in Sweden During the Early Months of the Outbreak-An Exploratory Cross-Sectional Analysis of a Population-Based Register Study. | Maripuu M et al. | β | 2020 | β |
| Early environmental factors and somatic comorbidity in schizophrenia and nonschizophrenic psychoses: A 50-year follow-up of the Northern Finland Birth Cohort 1966. | Korpela H et al. | β | 2020 | β |
| Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology. | Barnes TR et al. | β | 2020 | β |
| Examining healthcare professionals' beliefs and actions regarding the physical health of people with schizophrenia. | Berry A et al. | β | 2020 | β |
| Excess mortality from breast cancer in female breast cancer patients with severe mental illness. | AhlgrΓ©n-RimpilΓ€inen AJ et al. | β | 2020 | β |
| Gender differences in early onset of chronic physical multimorbidities in schizophrenia spectrum disorder: Do women suffer more? | Ε imunoviΔ FilipΔiΔ I et al. | β | 2020 | β |
| Health disparities among breast cancer patients with/without disabilities in Germany. | GroΓ SE et al. | β | 2020 | β |
| High frequency of clinical conditions commonly associated with mitochondrial disorders in schizophrenia. | Alonso Y et al. | β | 2020 | β |
| Identification of 34 genes conferring genetic and pharmacological risk for the comorbidity of schizophrenia and smoking behaviors. | Ma Y et al. | β | 2020 | β |
| Impact of schizophrenia genetic liability on the association between schizophrenia and physical illness: data-linkage study. | Kendall KM et al. | β | 2020 | β |
| Initial psychometric evaluation of the physical health attitude scale and a survey of mental health nurses. | Γzaslan Z et al. | β | 2020 | β |
| Mental health nurses' experience of physical health care and health promotion initiatives for people with severe mental illness. | LundstrΓΆm S et al. | β | 2020 | β |
| Metabolic changes of Japanese schizophrenic patients transferred from hospitalization to outpatients. | Uju Y et al. | β | 2020 | β |
| Mortality and suicide in schizophrenia: 21-year follow-up in rural China. | Ran MS et al. | β | 2020 | β |
| Mortality, Revascularization, and Cardioprotective Pharmacotherapy After Acute Coronary Syndrome in Patients With Psychotic Disorders: A Population-Based Cohort Study. | Chang WC et al. | β | 2020 | β |
| Mortality risk from long-term treatment with antipsychotic polypharmacy vs monotherapy among adults with serious mental illness: A systematic review and meta-analysis of observational studies. | Buhagiar K et al. | β | 2020 | β |
| Prevalence and major risk factors of type 2 diabetes mellitus among adult psychiatric inpatients from 2005 to 2018 in Beijing, China: a longitudinal observational study. | Yang F et al. | β | 2020 | β |
| Psychiatry's Future: Biology, Psychology, Legislation, and "The Fierce Urgency of <i>Now</i>". | Kelly BD | β | 2020 | β |
| Psychosocial therapies in severe mental illness: update on evidence and recommendations. | GΓΌhne U et al. | β | 2020 | β |
| Regulation of Reactive Oxygen Species-Mediated Damage in the Pathogenesis of Schizophrenia. | Madireddy S et al. | β | 2020 | β |
| Retinal correlates of psychiatric disorders. | Almonte MT et al. | β | 2020 | β |
| Role of Infection, Autoimmunity, Atopic Disorders, and the Immune System in Schizophrenia: Evidence from Epidemiological and Genetic Studies. | Benros ME et al. | β | 2020 | β |
| Schizophrenia. | Hasan A et al. | β | 2020 | β |
| Sleep Quality in Caregivers of Older Patients with Schizophrenia Spectrum and Bipolar Disorders: A Case-Control Study. | Fekih-Romdhane F et al. | β | 2020 | β |
| The overall and sex- and age-group specific incidence rates of cancer in people with schizophrenia: a population-based cohort study. | Pettersson D et al. | β | 2020 | β |
| The relevance of transdiagnostic shared networks to the severity of symptoms and cognitive deficits in schizophrenia: a multimodal brain imaging fusion study. | Qi S et al. | β | 2020 | β |
| The role of comorbidity in the association of obesity with unemployment and disability. | Le Strat Y et al. | β | 2020 | β |
| Antipsychotics and risk of natural death in patients with schizophrenia. | Chen Y et al. | β | 2019 | β |
| A randomised controlled trial of a case management approach to encourage participation in colorectal cancer screening for people with schizophrenia in psychiatric outpatient clinics: study protocol for the J-SUPPORT 1901 (ACCESS) study. | Fujiwara M et al. | β | 2019 | β |
| Association between thyroid function and metabolic syndrome in male and female schizophrenia patients. | Kalinowska S et al. | β | 2019 | β |
| Association of First- vs. Second-Generation Antipsychotics with Lipid Abnormalities in Individuals with Severe Mental Illness: A Systematic Review and Meta-Analysis. | Buhagiar K et al. | β | 2019 | β |
| Associations Between Physical Health Limitations and Community Participation Among People With and Without Serious Mental Illnesses. | Townley G et al. | β | 2019 | β |
| Bridge: Person-Centered Collaborative Care for Patients with Serious Mental Illness and Cancer. | Irwin KE et al. | β | 2019 | β |
| Cardiovascular effects of psychotic illnesses and antipsychotic therapy. | Howell S et al. | β | 2019 | β |
| Caring for patients with mental disorders in primary care: a qualitative study on French GPs' views, atittudes and needs. | Jego M et al. | β | 2019 | β |
| Change in smoking cessation stage over 1βyear in patients with schizophrenia: a follow up study in Japan. | Higuchi Y et al. | β | 2019 | β |
| Clozapine, Diabetes Mellitus, Cardiovascular Risk and Mortality: Results of a 21-Year Naturalistic Study in Patients with Schizophrenia and Schizoaffective Disorder. | Nemani KL et al. | β | 2019 | β |
| Excess medical comorbidity and mortality across the lifespan in schizophrenia.: A nationwide Danish register study. | Brink M et al. | β | 2019 | β |
| Expanding Access to Cancer Clinical Trials for Patients With Mental Illness. | Irwin KE et al. | β | 2019 | β |
| Health-related lifestyle and perceived health among people with severe mental illness: Gender differences and degree of sense of coherence. | LundstrΓΆm S et al. | β | 2019 | β |
| Improving Lung Cancer Screening Access for Individuals With Serious Mental Illness. | Flores EJ et al. | β | 2019 | β |
| Increased Dietary Inflammatory Index Is Associated with Schizophrenia: Results of a Case-Control Study from Bahrain. | Jahrami H et al. | β | 2019 | β |
| Increased mortality from somatic multimorbidity in patients with schizophrenia: a Danish nationwide cohort study. | Kugathasan P et al. | β | 2019 | β |
| Increased peripheral levels of TARC/CCL17 in first episode psychosis patients. | Malmqvist A et al. | β | 2019 | β |
| Increased risk of smoking-related illnesses in schizophrenia patients: A nationwide cohort study. | Krieger I et al. | β | 2019 | β |
| Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models. | Pillinger T et al. | β | 2019 | β |
| Lung Cancer Screening Eligibility, Risk Perceptions, and Clinician Delivery of Tobacco Cessation Among Patients With Schizophrenia. | Irwin KE et al. | β | 2019 | β |
| Mental disorders and medical comorbidities: Association rule mining approach. | Wang CH et al. | β | 2019 | β |
| Metabolic syndrome among older adults with schizophrenia spectrum disorder: Prevalence and associated factors in a multicenter study. | Abou Kassm S et al. | β | 2019 | β |
| Methylation age acceleration does not predict mortality in schizophrenia. | Kowalec K et al. | β | 2019 | β |
| Mortality and Medical Comorbidity in the Severely Mentally Ill. | Schneider F et al. | β | 2019 | β |
| Mortality of site-specific cancer in patients with schizophrenia: a systematic review and meta-analysis. | Ni L et al. | β | 2019 | β |
| Pain intensity, depressive symptoms, and functional limitations among older adults with serious mental illness. | Brooks JM et al. | β | 2019 | β |
| Physical health status of older adults with severe mental illness: The PHiSMI-E cohort study. | Houben N et al. | β | 2019 | β |
| Risk of readmission in patients with schizophrenia and schizoaffective disorder newly prescribed clozapine. | Kesserwani J et al. | β | 2019 | β |
| Self-Reported Pain Intensity and Depressive Symptoms Among Community-Dwelling Older Adults with Schizophrenia Spectrum Disorders. | Brooks JM et al. | β | 2019 | β |
| The impact of psychiatric utilisation prior to cancer diagnosis on survival of solid organ malignancies. | Klaassen Z et al. | β | 2019 | β |
| The relationship between childhood trauma, dopamine release and dexamphetamine-induced positive psychotic symptoms: a [<sup>11</sup>C]-(+)-PHNO PET study. | Dahoun T et al. | β | 2019 | β |
| Undiagnosed cardiovascular disease prior to cardiovascular death in individuals with severe mental illness. | Heiberg IH et al. | β | 2019 | β |
| Using an Integrated Care Pathway for Late-Life Schizophrenia Improves Monitoring of Adverse Effects of Antipsychotics and Reduces Antipsychotic Polypharmacy. | Abdool PS et al. | β | 2019 | β |
| Active listing and more consultations in primary care are associated with shorter mean hospitalisation and interacting with psychiatric disorders when adjusting for multimorbidity, age and sex. | Ranstad K et al. | β | 2018 | β |
| Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia. | Taipale H et al. | β | 2018 | β |
| Autoimmune diseases are associated with an increased risk of schizophrenia: A nationwide population-based cohort study. | Wang LY et al. | β | 2018 | β |
| Cardiometabolic comorbidities and life expectancy in people on medication for schizophrenia in Australia. | Castle DJ et al. | β | 2018 | β |
| Enabling healthy living: Experiences of people with severe mental illness in psychiatric outpatient services. | Blomqvist M et al. | β | 2018 | β |
| End-of-Life Care Preferences in Patients with Severe and Persistent Mental Illness and Chronic Medical Conditions: A Comparative Cross-Sectional Study. | Elie D et al. | β | 2018 | β |
| Family doctors providing primary care to patients with mental illness in a tertiary care facility. | McCracken RK et al. | β | 2018 | β |
| Genetic correlation between smoking behaviors and schizophrenia. | Hartz SM et al. | β | 2018 | β |
| Health Risks among People with Severe Mental Illness in Psychiatric Outpatient Settings. | Blomqvist M et al. | β | 2018 | β |
| Higher participation in physical activity is associated with less use of inpatient mental health services: A cross-sectional study. | Korge J et al. | β | 2018 | β |
| Hypertension risk and clinical care in patients with bipolar disorder or schizophrenia; a systematic review and meta-analysis. | Ayerbe L et al. | β | 2018 | β |
| IL-33/ST2 Pathway and Galectin-3 as a New Analytes in Pathogenesis and Cardiometabolic Risk Evaluation in Psychosis. | Borovcanin MM et al. | β | 2018 | β |
| Impact of schizophrenia and related disorders on mortality from breast cancer: A population-based cohort study in Denmark, 1995-2011. | Dalton SO et al. | β | 2018 | β |
| Increased cardiovascular mortality in people with schizophrenia: a 24-year national register study. | Westman J et al. | β | 2018 | β |
| Increased long-term mortality after myocardial infarction in patients with schizophrenia. | Kugathasan P et al. | β | 2018 | β |
| Is It Possible to Predict the Future in First-Episode Psychosis? | Suvisaari J et al. | β | 2018 | β |
| Is the risk of antipsychotic polypharmacy discontinuation dependent on the agents used? | Constantine RJ et al. | β | 2018 | β |
| Longitudinal assessment of the effect of cannabis use on hospital readmission rates in early psychosis: A 6-year follow-up in an inpatient cohort. | Colizzi M et al. | β | 2018 | β |
| Master's level mental health nursing competencies, a prerequisite for equal health among service users in mental health care. | Jormfeldt H et al. | β | 2018 | β |
| Metabolic screening for patients with second-generation antipsychotic medication: A population-based study from 2004 to 2016. | Lee EHM et al. | β | 2018 | β |
| Morbidity burden and community-based palliative care are associated with rates of hospital use by people with schizophrenia in the last year of life: A population-based matched cohort study. | Spilsbury K et al. | β | 2018 | β |
| Mortality in people with psychotic disorders in Finland: A population-based 13-year follow-up study. | KeinΓ€nen J et al. | β | 2018 | β |
| Natural cause mortality in persons with serious mental illness. | Dickerson F et al. | β | 2018 | β |
| Peer support and mobile health technology targeting obesity-related cardiovascular risk in young adults with serious mental illness: Protocol for a randomized controlled trial. | Aschbrenner KA et al. | β | 2018 | β |
| Prevalence and predictors of metabolic syndrome in patients with schizophrenia and healthy controls: A study in rural South Indian population. | Rawat VS et al. | β | 2018 | β |
| Prevalence of underweight in patients with schizophrenia: A meta-analysis. | Sugawara N et al. | β | 2018 | β |
| Quality and Predictors of Diabetes Care Among Patients With Schizophrenia: A Danish Nationwide Study. | JΓΈrgensen M et al. | β | 2018 | β |
| Quality of care and clinical outcomes of chronic obstructive pulmonary disease in patients with schizophrenia. A Danish nationwide study. | JΓΈrgensen M et al. | β | 2018 | β |
| Real-world adherence and economic outcomes associated with paliperidone palmitate versus oral atypical antipsychotics in schizophrenia patients with substance-related disorders using Medicaid benefits. | Joshi K et al. | β | 2018 | β |
| Risk factors for early circulatory mortality in patients with schizophrenia. | Chung KH et al. | β | 2018 | β |
| Risk of gastrointestinal Hypomotility in schizophrenia and schizoaffective disorder treated with antipsychotics: A retrospective cohort study. | Chen HK et al. | β | 2018 | β |
| Second-generation antipsychotic drugs and short-term mortality: a systematic review and meta-analysis of placebo-controlled randomised controlled trials. | Schneider-Thoma J et al. | β | 2018 | β |
| Severe mental illness and chronic kidney disease: a cross-sectional study in the United Kingdom. | Iwagami M et al. | β | 2018 | β |
| Social Disconnection in Schizophrenia and the General Community. | Green MF et al. | β | 2018 | β |
| Temporal trends in cardiovascular disease risk factor profiles in a population-based schizophrenia sample: a repeat cross-sectional study. | Chiu M et al. | β | 2018 | β |
| What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia? | Correll CU et al. | β | 2018 | β |
| Altered reward anticipation: Potential explanation for weight gain in schizophrenia? | Grimm O et al. | β | 2017 | β |
| Antipsychotic medications and stroke in schizophrenia: A case-crossover study. | Chen WY et al. | β | 2017 | β |
| Associations between physical activity and motivation, competence, functioning, and apathy in inhabitants with mental illness from a rural municipality: a cross-sectional study. | Farholm A et al. | β | 2017 | β |
| Atrial fibrillation in patients with severe mental disorders and the risk of stroke, fatal thromboembolic events and bleeding: a nationwide cohort study. | SΓΈgaard M et al. | β | 2017 | β |
| Canadian Schizophrenia Guidelines: Schizophrenia and Other Psychotic Disorders with Coexisting Substance Use Disorders. | Crockford D et al. | β | 2017 | β |
| Cancer mortality in patients with schizophrenia: systematic review and meta-analysis. | Zhuo C et al. | β | 2017 | β |
| Cancer prevalence in Israeli men and women with schizophrenia. | Agay N et al. | β | 2017 | β |
| Causes and predictors of premature death in first-episode schizophrenia spectrum disorders. | Melle I et al. | β | 2017 | β |
| Changes in metabolic parameters in patients with severe mental illness over a 10-year period: A retrospective cohort study. | Heald AH et al. | β | 2017 | β |
| Cholesterol and triglyceride levels in first-episode psychosis: systematic review and meta-analysis. | Pillinger T et al. | β | 2017 | β |
| Clozapine as a Model for Antipsychotic Development. | Nucifora FC et al. | β | 2017 | β |
| Common adult psychiatric disorders in Swedish primary care where most mental health patients are treated. | Sundquist J et al. | β | 2017 | β |
| Comorbidities with chronic physical conditions and gender profiles of illness in schizophrenia. Results from PREST, a new health dataset. | Gabilondo A et al. | β | 2017 | β |
| Cost-effectiveness of 3-month paliperidone treatment for chronic schizophrenia in Spain. | Einarson TR et al. | β | 2017 | β |
| Do adverse perinatal events predict mortality in schizophrenia during midlife? | Rautio N et al. | β | 2017 | β |
| Effectiveness, efficiency and efficacy in the multidimensional treatment of schizophrenia: Rethinking project. | Crespo-Facorro B et al. | β | 2017 | β |
| Effect of stage, comorbidities and treatment on survival among cancer patients with or without mental illness. | Manderbacka K et al. | β | 2017 | β |
| Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas. | Liu NH et al. | β | 2017 | β |
| Exercise Treatments for Psychosis: A Review. | Mittal VA et al. | β | 2017 | β |
| Familial liability to psychosis is a risk factor for multimorbidity in people with psychotic disorders and their unaffected siblings. | Islam MA et al. | β | 2017 | β |
| Health care use, drug treatment and comorbidity in patients with schizophrenia or non-affective psychosis in Sweden: a cross-sectional study. | Brostedt EM et al. | β | 2017 | β |
| Impact of Medicaid prescription copayments on use of antipsychotics and other medications in patients with schizophrenia. | Doshi JA et al. | β | 2017 | β |
| Impaired Glucose Homeostasis in First-Episode Schizophrenia: A Systematic Review and Meta-analysis. | Pillinger T et al. | β | 2017 | β |
| Improving life expectancy in people with serious mental illness: should we place more emphasis on primary prevention? | Ilyas A et al. | β | 2017 | β |
| [Medication-free hospital records - a measure not based on knowledge]. | RΓΈssberg JI et al. | β | 2017 | β |
| Mortality and the relationship of somatic comorbidities to mortality in schizophrenia. A nationwide matched-cohort study. | Bitter I et al. | β | 2017 | β |
| Multiple physical healthcare needs among outpatients with schizophrenia: findings from a health examination study. | Eskelinen S et al. | β | 2017 | β |
| Oxytocin system dysfunction as a common mechanism underlying metabolic syndrome and psychiatric symptoms in schizophrenia and bipolar disorders. | Quintana DS et al. | β | 2017 | β |
| Physical Health, Medication, and Healthcare Utilization among 70-Year-Old People with Schizophrenia: A Nationwide Danish Register Study. | Brink M et al. | β | 2017 | β |
| Predictors of Disruptions in Breast Cancer Care for Individuals with Schizophrenia. | Irwin KE et al. | β | 2017 | β |
| Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. | Correll CU et al. | β | 2017 | β |
| Providing Tobacco Treatment in a Community Mental Health Setting: A Pilot Study. | Okoli CT et al. | β | 2017 | β |
| Quality of Care and Outcomes of Heart Failure Among Patients With Schizophrenia in Denmark. | JΓΈrgensen M et al. | β | 2017 | β |
| Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29β―823 Patients With Schizophrenia. | Tiihonen J et al. | β | 2017 | β |
| Relative risks of cardiovascular disease in people prescribed olanzapine, risperidone and quetiapine. | Osborn D et al. | β | 2017 | β |
| The Patients We Have to See. | Irwin KE | β | 2017 | β |
| Topiramate's effectiveness on weight reduction in overweight/obese persons with schizophrenia: study protocol for a randomized controlled trial. | Chandradasa M et al. | β | 2017 | β |
| What does mental health nursing contribute to improving the physical health of service users with severe mental illness? A thematic analysis. | Gray R et al. | β | 2017 | β |
| Association Between Antipsychotic Treatment and Advanced Diabetes Complications Among Schizophrenia Patients With Type 2 Diabetes Mellitus. | Wu CS et al. | β | 2016 | β |
| Cancer screening, prevention, and treatment in people with mental illness. | Weinstein LC et al. | β | 2016 | β |
| Cardiovascular disease treatment among patients with severe mental illness: a data linkage study between primary and secondary care. | Woodhead C et al. | β | 2016 | β |
| CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 30-2016. A 63-Year-Old Woman with Bipolar Disorder, Cancer, and Worsening Depression. | Irwin KE et al. | β | 2016 | β |
| Clinically useful predictors for premature mortality among psychiatric patients visiting a psychiatric emergency room. | Aagaard J et al. | β | 2016 | β |
| Comorbidity of schizophrenia and infection: a population-based cohort study. | Nielsen PR et al. | β | 2016 | β |
| Comparative Effectiveness of Clozapine and Standard Antipsychotic Treatment in Adults With Schizophrenia. | Stroup TS et al. | β | 2016 | β |
| Consideration of Clozapine and Gender-Affirming Medical Care for an HIV-Positive Person with Schizophrenia and Fluctuating Gender Identity. | Gerken AT et al. | β | 2016 | β |
| Diabetes treatment in people with type 2 diabetes and schizophrenia: Retrospective primary care database analyses. | Rathmann W et al. | β | 2016 | β |
| Differences in cancer stage, treatment and in-hospital mortality between patients with and without schizophrenia: retrospective matched-pair cohort study. | Ishikawa H et al. | β | 2016 | β |
| Effects of an electronic reminder system on guideline-concordant treatment of psychotic disorders : Results from aΒ pilot feasibility trial. | Franke I et al. | β | 2016 | β |
| Factors associated with overweight and obesity in schizophrenia, schizoaffective and bipolar disorders. | Chouinard VA et al. | β | 2016 | β |
| Health care disparities among persons with comorbid schizophrenia and cardiovascular disease: a case-control epidemiological study. | Gal G et al. | β | 2016 | β |
| Including Underrepresented Subgroups of Smokers in Tobacco Regulation Research. | Weinberger AH | β | 2016 | β |
| Ischemic Colitis as a Complication of Medication Use: An Analysis of the Federal Adverse Event Reporting System. | Bielefeldt K | β | 2016 | β |
| Life Satisfaction and Morbidity among Postmenopausal Women. | Lukkala PS et al. | β | 2016 | β |
| Mortality Among Persons With Obsessive-Compulsive Disorder in Denmark. | Meier SM et al. | β | 2016 | β |
| Mortality and Cumulative Exposure to Antipsychotics, Antidepressants, and Benzodiazepines in Patients With Schizophrenia: An Observational Follow-Up Study. | Tiihonen J et al. | β | 2016 | β |
| Mortality in schizophrenia and bipolar disorder: Clinical and serological predictors. | Dickerson F et al. | β | 2016 | β |
| Multisite prediction of 4-week and 52-week treatment outcomes in patients with first-episode psychosis: a machine learning approach. | Koutsouleris N et al. | β | 2016 | β |
| Number of children and later-life mortality among Finns born 1938-50. | EiniΓΆ E et al. | β | 2016 | β |
| Obstructive sleep apnea: Underestimated risk factor in sudden cardiac death in schizophrenia. | Scorza FA et al. | β | 2016 | β |
| Once-monthly paliperidone palmitate in recently diagnosed and chronic non-acute patients with schizophrenia. | Hargarter L et al. | β | 2016 | β |
| Palliative psychiatry for severe persistent mental illness as a new approach to psychiatry? Definition, scope, benefits, and risks. | Trachsel M et al. | β | 2016 | β |
| Pharmacokinetic considerations in the treatment of hypertension in risperidone-medicated patients - thinking of clinically relevant CYP2D6 interactions. | Paulzen M et al. | β | 2016 | β |
| Physiological characteristics of patients with schizophrenia prematurely dying from circulatory diseases. | Chen PH et al. | β | 2016 | β |
| Probable clozapine-induced parenchymal lung disease and perimyocarditis: a case report. | Bugge E et al. | β | 2016 | β |
| Psychiatric comorbidities in patients with hypertension--a study of registered diagnoses 2009-2013 in the total population in Stockholm County, Sweden. | SandstrΓΆm YK et al. | β | 2016 | β |
| Real-world effectiveness of antipsychotics. | Tiihonen J | β | 2016 | β |
| Reducing excess mortality due to chronic disease in people with severe mental illness: meta-review of health interventions. | Baxter AJ et al. | β | 2016 | β |
| Ten-Year Mortality after a Breast Cancer Diagnosis in Women with Severe Mental Illness: A Danish Population-Based Cohort Study. | Ribe AR et al. | β | 2016 | β |
| The prevalence and risk factors of stroke in patients with chronic schizophrenia. | Liang Y et al. | β | 2016 | β |
| Treatment is necessary! | Kripalani M | β | 2016 | β |
| Antihypertensive treatment and control according to gender, education, country of birth and psychiatric disorder: the Swedish Primary Care Cardiovascular Database (SPCCD). | Ljungman C et al. | β | 2015 | β |
| Antipsychotic treatment and mortality in schizophrenia. | Torniainen M et al. | β | 2015 | β |
| Asymmetric dimethylarginine in somatically healthy schizophrenia patients treated with atypical antipsychotics: a case-control study. | Jorgensen A et al. | β | 2015 | β |
| Cardiovascular risk prediction models for people with severe mental illness: results from the prediction and management of cardiovascular risk in people with severe mental illnesses (PRIMROSE) research program. | Osborn DP et al. | β | 2015 | β |
| Clozapine use and sedentary lifestyle as determinants of metabolic syndrome in outpatients with schizophrenia. | Eskelinen S et al. | β | 2015 | β |
| Consumer-Involved Participatory Research to Address General Medical Health and Wellness in a Community Mental Health Setting. | Iyer SP et al. | β | 2015 | β |
| Diabetes and glucose disturbances in patients with psychosis in Sweden. | Olsson E et al. | β | 2015 | β |
| Excess mortality from mental, neurological and substance use disorders in the Global Burden of Disease Study 2010. | Charlson FJ et al. | β | 2015 | β |
| Health screening, counseling, and hypertension control for people with serious mental illness at primary care visits. | Iyer SP et al. | β | 2015 | β |
| Increased Silent Brain Infarction Accompanied With High Prevalence of Diabetes and Dyslipidemia in Psychiatric Inpatients: A Cross-Sectional Study. | Kanzaki T et al. | β | 2015 | β |
| Lung function and respiratory diseases in people with psychosis: population-based study. | Partti K et al. | β | 2015 | β |
| Microvascular dysfunction in schizophrenia: a case-control study. | Vetter MW et al. | β | 2015 | β |
| Mortality in schizophrenia and other psychoses: a 10-year follow-up of the ΣSOP first-episode cohort. | Reininghaus U et al. | β | 2015 | β |
| [Pain therapy in patients with schizoaffective disorder and cancer]. | Brinkers M et al. | β | 2015 | β |
| Productivity loss and resource utilization, and associated indirect and direct costs in individuals providing care for adults with schizophrenia in the EU5. | Gupta S et al. | β | 2015 | β |
| Promoting physical health for people with schizophrenia by reducing disparities in medical and dental care. | Moore S et al. | β | 2015 | β |
| Retinal microvessels reflect familial vulnerability to psychotic symptoms: A comparison of twins discordant for psychotic symptoms and controls. | Meier MH et al. | β | 2015 | β |
| Risk factors for sudden cardiac death among patients with schizophrenia. | Hou PY et al. | β | 2015 | β |
| Role of the Sympathetic Nervous System in Stress-Mediated Cardiovascular Disease. | Hering D et al. | β | 2015 | β |
| Serving persons with severe mental illness in primary care-based medical homes. | Domino ME et al. | β | 2015 | β |
| Survival analysis of the use of first and second generation antipsychotics among patients suffering schizophrenia: A nationwide population-based cohort study. | Chen VC et al. | β | 2015 | β |
| Telomere length in blood cells is related to the chronicity, severity, and recurrence rate of schizophrenia. | Pawelczyk T et al. | β | 2015 | β |
| Ten-Year Outcomes of First-Episode Psychoses in the MRC ΓSOP-10 Study. | Revier CJ et al. | β | 2015 | β |
| The effect of clozapine on premature mortality: an assessment of clinical monitoring and other potential confounders. | Hayes RD et al. | β | 2015 | β |
| The effect of pre-existing mental health comorbidities on the stage at diagnosis and timeliness of care of solid tumor malignances in a Veterans Affairs (VA) medical center. | Wadia RJ et al. | β | 2015 | β |
| The global burden of mental, neurological and substance use disorders: an analysis from the Global Burden of Disease Study 2010. | Whiteford HA et al. | β | 2015 | β |
| The relationship between schizophrenia and rheumatoid arthritis revisited: genetic and epidemiological analyses. | Euesden J et al. | β | 2015 | β |
| Thirty-Day Mortality After Infection Among Persons With Severe Mental Illness: A Population-Based Cohort Study in Denmark. | Ribe AR et al. | β | 2015 | β |
| A 12-week weight reduction intervention for overweight individuals taking antipsychotic medications. | Green CA et al. | β | 2014 | β |
| Addressing the disparity in physical health provision for people with schizophrenia: an important role for physiotherapists. | Stubbs B et al. | β | 2014 | β |
| Barriers, benefits, and strategies for physical activity in patients with schizophrenia. | Rastad C et al. | β | 2014 | β |
| Behavioral Health Homes: an opportunity to address healthcare inequities in people with serious mental illness. | Viron M et al. | β | 2014 | β |
| Cancer care for individuals with schizophrenia. | Irwin KE et al. | β | 2014 | β |
| Cardiovascular drug use and mortality in patients with schizophrenia or bipolar disorder: a Danish population-based study. | Laursen TM et al. | β | 2014 | β |
| Comorbidity of severe psychotic disorders with measures of substance use. | Hartz SM et al. | β | 2014 | β |
| Enhancing outreach for persons with serious mental illness: 12-month results from a cluster randomized trial of an adaptive implementation strategy. | Kilbourne AM et al. | β | 2014 | β |
| Estimating the population attributable fraction for schizophrenia when Toxoplasma gondii is assumed absent in human populations. | Smith G | β | 2014 | β |
| Excess early mortality in schizophrenia. | Laursen TM et al. | β | 2014 | β |
| Health-related quality of life and metabolic risk in patients with psychosis. | Foldemo A et al. | β | 2014 | β |
| Impact of socioeconomic deprivation on rate and cause of death in severe mental illness. | Martin JL et al. | β | 2014 | β |
| Inflammation and the two-hit hypothesis of schizophrenia. | Feigenson KA et al. | β | 2014 | β |
| Integrated care: nonfasting screening for cardiovascular risk among individuals taking second-generation antipsychotics. | Vanderlip ER et al. | β | 2014 | β |
| Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies. | CatalΓ‘-LΓ³pez F et al. | β | 2014 | β |
| Life satisfaction and bone mineral density among postmenopausal women: cross-sectional and longitudinal associations. | Rauma PH et al. | β | 2014 | β |
| Mental disorders across the adult life course and future coronary heart disease: evidence for general susceptibility. | Gale CR et al. | β | 2014 | β |
| Mortality in schizophrenia: clinical and serological predictors. | Dickerson F et al. | β | 2014 | β |
| Nutritional interventions for the adjunctive treatment of schizophrenia: a brief review. | Arroll MA et al. | β | 2014 | β |
| Patterns of physical co-/multi-morbidity among patients with serious mental illness: a London borough-based cross-sectional study. | Woodhead C et al. | β | 2014 | β |
| Pharmacotherapy of Co-Occurring Schizophrenia and Substance Use Disorders. | Akerman SC et al. | β | 2014 | β |
| Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions. | Schoepf D et al. | β | 2014 | β |
| Plasma omentin levels in drug-free patients with schizophrenia. | Yildirim O et al. | β | 2014 | β |
| Psychotic disorder is an independent risk factor for increased fasting glucose and waist circumference. | Osby U et al. | β | 2014 | β |
| Risks of all-cause and suicide mortality in mental disorders: a meta-review. | Chesney E et al. | β | 2014 | β |
| Schizophrenia and risk of stroke: a meta-analysis of cohort studies. | Li M et al. | β | 2014 | β |
| Schizophrenia--time to commit to policy change. | Fleischhacker WW et al. | β | 2014 | β |
| The adenosine neuromodulation system in schizophrenia. | Rial D et al. | β | 2014 | β |
| The assessment, benefits and delivery of physical activity in people with schizophrenia: a survey of members of the International Organization of Physical Therapists in Mental Health. | Stubbs B et al. | β | 2014 | β |
| The relationship between serum brain-derived neurotrophic factor (BDNF) and cardiometabolic indices in schizophrenia. | Nurjono M et al. | β | 2014 | β |
| Understanding the role of physiotherapists in schizophrenia: an international perspective from members of the International Organisation of Physical Therapists in Mental Health (IOPTMH). | Stubbs B et al. | β | 2014 | β |
| Cluster randomized adaptive implementation trial comparing a standard versus enhanced implementation intervention to improve uptake of an effective re-engagement program for patients with serious mental illness. | Kilbourne AM et al. | β | 2013 | β |
| Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia. | Severance EG et al. | β | 2013 | β |
| Mortality in persons with mental disorders is substantially overestimated using inpatient psychiatric diagnoses. | Crump C et al. | β | 2013 | β |
| Multimorbidity in bipolar disorder and undertreatment of cardiovascular disease: a cross sectional study. | Smith DJ et al. | β | 2013 | β |
| Schizophrenia is associated with excess multiple physical-health comorbidities but low levels of recorded cardiovascular disease in primary care: cross-sectional study. | Smith DJ et al. | β | 2013 | β |